Skip to content
AdminMay 12, 2023 10:24:00 AM< 1 min read

Trends in Genetic Testing for Alzheimer’s

With the approval of new drugs by Eisai and Biogen, genetic testing for Alzheimer’s is on the rise.


This article from Reuters cites a 125% increase in ApoE genetic testing in a four-month period around the approval of the Biogen drug in January. This was determined after review of medical records from nearly 8 million adults across 28 major US hospitals, so it did not account for any increase in DTC genetic testing. Since anti-selection is always a concern, this trend is worth noting.

 
Michael Fulks MDNov 9, 2023, 4:20:00 PM2 min read

The newest Alzheimer’s disease drug – lecanemab is approved. Will it really help?

Dr. Michael Fulks, Consulting Medical Director, discusses the latest results for the use of lecanemab in early Alzheimer’s ...
Start Reading
Dr. Michael Fulks MDAug 25, 2022, 2:50:00 PM3 min read

Alzheimer’s Dementia Onset: Study Examines the Impact of Lifestyle Factors on Life Expectancy

A Note from Dr. Robert Stout, CRL Chief Scientific Officer & Co-Founder
Start Reading
Michael Fulks MDOct 25, 2023, 3:00:00 PM1 min read

Dementia Prevalence in the U.S. May Be Declining (But Not Because of Any Alzheimer Rx)

Dr. Michael Fulks, Consulting Medical Director, highlights a report discussing how the prevalence of dementia has declined in ...
Start Reading